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Abstract
Purpose:  The  i-gelTM is  one  of  the  second  generation  supraglottic  airway  devices.  Our  study
was designed  to  compare  the  i-gel  and  the  Laryngeal  Mask  Airway  ClassicTM with  respect  to  the
clinical performance.
Methods:  We  compared  the  performance  of  the  i-gel  with  that  of  the  Laryngeal  Mask  Airway
Classic in  120  patients  undergoing  urologic  surgery  during  general  anesthesia  without  mus-
cle relaxant  with  respect  to  the  number  of  attempts  for  successful  insertion,  insertion  time,
peak airway  pressure,  incidence  of  regurgitation,  ﬁberoptic  glottic  view  and  postoperative
complications.  Second  generation  supraglottic  airway  devices  were  inserted  by  the  same  anes-
thesiologist,  experienced  in  use  of  both  devices  (>200  uses  and  ﬁrst  time  failure  rate  <5%).
Methylene  blue  method  was  used  to  detect  gastric  regurgitation.
Results:  There  was  no  statistical  difference  between  the  two  groups  regarding  the  success
of insertion  of  second  generation  supraglottic  airway  device  (p  =  0.951).  The  laryngeal  mask
insertion time  for  the  i-gel  group  was  signiﬁcantly  shorter  than  that  for  the  Laryngeal  Mask
Airway Classic  group  (11.6  ±  2.4  s  versus  13.1  ±  1.8  s  [p  =  0.001]).  The  ﬁberoptic  glottic  view
scores for  the  i-gel  group  was  signiﬁcantly  better  than  that  for  the  ones  for  the  Laryngeal  Mask
Airway Classic  group  (p  =  0.001).  On  ﬁberoptic  view,  there  was  no  sign  of  methylene  blue  dye
at any  time  point  in  either  group.  In  addition,  there  was  no  difference  between  the  groups
in patient  response  regarding  the  presence  of  a  sore  throat  when  questioned  24  h  after  the
procedure  (p  =  0.752).
Conclusion:  Both  devices  had  good  performance  with  low  postoperative  complications  and
without occurrence  of  regurgitation.  The  i-gel  provided  a  shorter  insertion  time  and  a  betterryngeal  Mask  Airway  Classic.
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Comparac¸ão  da  máscara  laríngea  i-gel  (i-gelTM)  com  a  máscara  laríngea  clássica
(LMA-ClassicTM)  em  relac¸ão ao  desempenho  clínico
Resumo
Justiﬁcativa  e  objetivo:  A  i-gel  é  um  dos  dispositivos  supraglóticos  de  segunda  gerac¸ão  para  o
manejo das  vias  aéreas.  Nosso  estudo  foi  projetado  para  comparar  a  i-gelTM e  a  máscara  laríngea
clássica  (Laryngeal  Mask  Airway  ClassicTM,  LMA-C)  em  relac¸ão  ao  desempenho  clínico.
Métodos:  Avaliamos  os  desempenhos  de  i-gel  e  LMA-C  em  120  pacientes  submetidos  à  cirurgia
urológica  sob  anestesia  geral  sem  relaxante  muscular.  Comparamos  o  número  de  tentativas  de
inserc¸ão bem-sucedidas,  o  tempo  de  inserc¸ão,  a  pressão  de  pico  das  vias  aéreas,  a  incidên-
cia de  regurgitac¸ão,  a  visibilidade  da  glote  com  o  uso  de  ﬁbra  óptica  e  as  complicac¸ões  no
pós-operatório.  Os  dispositivos  supraglóticos  de  segunda  gerac¸ão  foram  inseridos  pelo  mesmo
anestesiologista  com  experiência  na  aplicac¸ão  de  ambos  os  dispositivos  (>  200  aplicac¸ões  e
taxa de  falha  na  primeira  tentativa  <  5%).  O  corante  azul  de  metileno  foi  usado  para  detectar
regurgitac¸ão gástrica.
Resultados:  Não  houve  diferenc¸a  estatística  entre  os  dois  grupos  em  relac¸ão  ao  sucesso  da
inserc¸ão do  dispositivo  supraglótico  de  segunda  gerac¸ão  (p  =  0,951).  O  tempo  de  inserc¸ão
da máscara  laríngea  no  grupo  i-gel  foi  signiﬁcativamente  menor  do  que  no  grupo  LMA-C
(11,6 ±  2,4  segundos  vs.  13,1  ±  1,8  segundos,  p  =  0,001).  O  escore  de  visibilidade  da  glote  via
ﬁbra óptica  do  grupo  i-gel  foi  signiﬁcativamente  melhor  do  que  o  do  grupo  LMA-C  (p  =  0,001).
Na visão  via  ﬁbra  ótica,  sinais  do  corante  azul  de  metileno  não  foram  observados  em  qualquer
momento  em  ambos  os  grupos.  Além  disso,  não  houve  diferenc¸a  entre  as  respostas  dos  gru-
pos quando  perguntados  sobre  a  presenc¸a  de  dor  de  garganta  24  horas  após  o  procedimento
(p =  0,752).
Conclusão:  Ambos  os  dispositivos  apresentaram  bom  desempenho,  com  poucas  complicac¸ões
no pós-operatório  e  sem  ocorrência  de  regurgitac¸ão.  A  máscara  laríngea  i-gel  proporcionou  um
tempo de  inserc¸ão  mais  curto  e  uma  visão  via  ﬁbra  óptica  melhor  do  que  a  LMA-C.
© 2014  Sociedade  Brasileira  de  Anestesiologia.  Publicado  por  Elsevier  Editora  Ltda.  Todos  os
direitos reservados.
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ntroduction  of  Laryngeal  Mask  Airway  (LMA  ClassicTM;  [LMA-
]  Intavent  Orthoﬁx,  UK),  has  changed  the  practice  of
aintaining  safe  airway.1 Since  then,  supraglottic  airway
evices  (SGADs)  have  been  used  successfully  and  safely  in
nesthetic  practice  with  various  models,  and  have  under-
one  rapid  development.2,3 Almost  all  SGADs,  including  the
MA-C,  use  an  inﬂatable  cuff  to  wedge  into  the  upper  esoph-
gus  and  provide  a  perilaryngeal  seal.4 Accurate  positioning
nd  adequate  pressure  and  volume  within  the  cuff  are  fun-
amental  to  achieve  optimal  function,  and  to  reduce  the
omplications.  A  limiting  factor  for  the  use  of  SGAD  is
he  lack  of  airway  protection  from  gastric  contents.5,6 Sev-
ral  SGADs  are  now  marketed  that  are  speciﬁcally  designed
o  reduce  the  risk  of  aspiration.  The  i-gelTM (Intersurgical
td.,  UK)  is  one  of  the  second  generation  SGADs  produced
or  this  purpose.  The  cuff  of  the  i-gel  is  constructed  from
edical-grade  thermoplastic  elastomer  (styrene  ethylene
utadiene  styrene)  which  does  not  require  inﬂating  the  cuff
r  adjusting  intra-cuff  pressure.  Its  design  enables  a  mir-
ored  impression  of  the  pharyngeal  and  laryngeal  structures
nd  provides  a  perilaryngeal  seal  without  cuff  inﬂation.  The
otential  advantages  of  the  i-gel  are  easy  and  rapid  insertion
nd  a  reduction  in  the  risk  of  pharyngeal  tissue  compres-
ion  due  to  high  cuff  pressure.  Moreover,  it  has  an  inbuilt
rainage  channel,  which  allows  the  insertion  of  a  gastric
t
(
g
cube  (maximum  14F  gauge),  to  facilitate  the  eﬂux  of  gastric
uid  and  gas.
This  study  compares  the  clinical  performance  of  the  i-
el  with  the  LMA-C  in  terms  of  insertion  time,  the  number
f  attempts  for  successful  insertion,  peak  airway  pressure,
beroptic  glottic  view,  incidence  of  regurgitation,  and  post-
perative  complications  which  have  never  been  compared
n  a  randomized-prospective  study  in  adults  in  vivo  before.
ethods
his  study  was  conducted  between  June  and  September  2013
t  Diskapi  Yildirim  Beyazit  Research  and  Training  Hospital.
he  study  (ref:  06/27,  date:  12/17/2012)  was  approved  by
 local  research  ethics  committee.  A  total  of  120  patients,
ho  underwent  urologic  surgery  in  lithotomy  position  under
eneral  anesthesia  with  ASA  physical  status  I--III  (aged
8--70  years,  weight  50--90  kg),  were  assessed  and  writ-
en  informed  consent  was  taken  from  all  patients  enrolled
n  the  study.  Patients  with  a  history  of  gastroesophageal
eﬂux,  hiatal  hernia,  previous  gastric  surgery  or  body  mass
ndex  (BMI)  >35  kg/m2,  and  those  who  take  medications  for
isorders  of  gastrointestinal  motility  were  excluded  from
he  study.  The  patients  were  randomized  into  two  groups
group  LMA-C,  n  =  60,  or  group  i-gel,  n  =  60)  by  a  computer-
enerated  random  number  table.  The  insertion  of  SGADs  was
onducted  by  the  same  anesthesiologist  experienced  in  the
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BClinical  performance  of  supraglottic  airway  devices  
use  of  both  devices  (>200  uses  and  ﬁrst  time  failure  rate
<5%).
All  patients’  demographic  parameters  (gender,  age,
weight,  height  and  body  mass  index),  and  the  duration
of  surgery  were  recorded.  Patients  were  premedicated
with  0.04  mg/kg  midazolam  iv  approximately  30  min  before
induction  of  anesthesia.  A  gelatin  capsule  containing  methy-
lene  blue  powder  (25  mg  in  lactose  and  30  mL  of  water)
was  ingested  orally  in  sitting  position  by  the  patients  10  min
before  induction  of  anesthesia.  The  gelatin  capsule  dissolves
in  water  or  acidic  pH  1--5  solution  within  5  min  and  turns
the  gastric  contents  blue.7,8 Patient  heart  rate  (HR)  by  a
three-channel  ECG,  noninvasive  blood  pressure,  bispectral
index  (BIS)  (A-200  BIS  monitoring  system;  Aspect  Medical
systems,  BIS  XP;  Framingham,  MA,  USA),  and  pulse  oximetry
were  monitored.  Anesthetic  management  was  standardized
according  to  the  following  protocol.  Patients  were  pre-
oxygenated  for  2  min,  and  anesthesia  was  induced  with
propofol  (2--2.5  mg/kg)  and  fentanyl  (1.5--2  g/kg).  In  order
to  provide  consistent  conditions,  insertion  of  the  SGAD  was
made  when  the  BIS  was  below  60.  BIS  values  were  kept  sta-
ble  by  inhalational  anesthesia  throughout  the  study  period.
Each  device  was  lubricated  with  a  water-based  agent  and
inserted  according  to  the  manufacturer’s  recommendations.
Size  selection  of  the  i-gel  or  LMA-C  depended  on  patient’s
weight  in  accordance  with  the  guidelines.  The  LMA-C  cuffs
were  inﬂated  until  the  air  leak  sound  coming  from  the  mouth
ceased  (≤45  cm3 air).  In  order  to  maintain  adequate  cuff
pressure  for  LMA-C,  cuff  pressure  was  maintained  in  by  using
a  handheld  pressure  gauge  (VBM  Medizintechnik  GmbH,  Sulz
a.N.,  Germany).
Anesthesia  was  maintained  with  1.5--2%  sevoﬂurane  in
50%  oxygen--air  mixture  without  using  any  neuromuscular
blockers,  and  remifentanil  infusion  was  started  at  a  dose  of
0.2--0.3  g/kg/min.  Manual  bag  ventilation  was  maintained
in  all  patients  through  a  circle  system  until  insertion  of  SGAD
and  validation  of  placement.
In  order  to  insert  the  SGAD,  a  maximum  of  three  attempts
was  made  for  each  group.  If  it  was  not  possible  to  ventilate
the  lungs,  the  following  adjustments  were  allowed:  neck
extension  or  ﬂexion,  chin  lift,  jaw  thrust  and  gentle  push-
ing  or  pulling  of  the  device.  When  insertion  of  both  SGAD
models  failed,  the  subject  was  excluded  from  the  study  and
the  airway  was  maintained  by  an  endotracheal  tube.  Cor-
rect  insertion  was  assessed  by  proper  chest  expansion,  the
presence  of  a  curved  CO2 wave  on  the  capnography,  the
absence  of  audible  leak,  and  lack  of  gastric  insufﬂation.  The
presence  of  gastric  insufﬂation  was  determined  by  epigas-
tric  auscultation.  In  both  groups,  insertion  success  of  the
SGAD  (the  number  of  airway  manipulations),  time  required
to  establish  the  airway  (the  total  time  from  grasping  of
the  device  to  observing  a  square  wave  capnograph  trace)
and  complications  such  as  laryngospasm,  apnea,  or  hiccups
were  recorded.  After  obtaining  an  effective  airway,  the
device  was  connected  to  a  circle  breathing  system  (Primus,
Drager,  Lubek,  Germany).  The  lungs  were  ventilated  with  a
tidal  volume  of  7  mL  kg−1,  a  respiratory  rate  of  12  breaths
per  minute,  and  I:E  ratio  of  1:2  and  peak  airway  pres-
sure  of  approximately  12--20  cm  H2O  in  volume  controlled
mode.  Peak  airway  pressure  values  were  recorded.  After
ensuring  satisfactory  ventilation,  the  anatomical  position  of
LMA-C  and  i-gel  was  assessed  using  a  ﬁberoptic  endoscope
t
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2.8  mm;  Olympus,  Tokyo,  Japan)  via  the  airway  tube  of  the
evice.  The  ﬁberscope  was  always  kept  straight  (anatomi-
al  position)  to  maintain  control  over  the  tip.  The  tip  of  the
berscope  was  positioned  just  above  the  bars  of  the  LMA-C
r  i-gel.  The  view  via  the  airway  channels  was  scored  as  fol-
ows:  Grade  4,  only  vocal  cords  are  viewed;  Grade  3,  vocal
ords  and  posterior  epiglottis  are  viewed;  Grade  2,  vocal
ords  and  anterior  epiglottis  are  viewed;  Grade  1,  cords  are
ot  viewed  but  functioning  adequately.9,10
To  prevent  false-positive  regurgitation,  the  oropharyn-
eal  cavity  was  inspected  for  blue  dye.  After  insertion  of
GAD,  the  presence  or  absence  of  blue  dye  in  the  bowl  was
ssessed  using  a  ﬁberscope.  Additionally,  before  SGAD  was
emoved,  ﬁberscopy  was  repeated  again  to  ﬁnd  out  traces  of
ethylene  blue  in  all  the  patients  at  the  end  of  the  surger-
es.  After  removal  of  SGAD,  the  devices  used  for  ﬁberscopy
ere  inspected  visually  for  trace  of  blue  staining  and  blood
y  one  of  the  investigators  and  the  results  of  these  inspec-
ions  were  recorded.
Once  surgery  was  completed,  sevoﬂurane  and  remifen-
anil  were  discontinued.  When  the  patient  was  able  to  open
is  or  her  mouth  following  our  command,  the  airway  device
as  removed  after  pharyngeal  suctioning  and  lifting  of  the
aw.  Then,  the  patient  was  given  100%  oxygen  via  facemask
or  10  min.
The  patients  were  interviewed  in  the  post-anesthetic
are  unit  by  nurses  who  were  blind  to  study,  with  respect  to
he  presence  of  sore  throat  and  dysphagia.  When  modiﬁed
ldrete  scores  were  10  and  above,  the  patients  were  trans-
erred  to  their  rooms.  Twenty-four  hours  after  surgery,  the
atients  were  asked  one  more  time  if  they  had  sore  throat
nd  dysphagia.
tatistical  analysis
he  sample  size  of  55  per  group  was  determined  by  power
nalysis;  due  to  the  preliminary  study  results  of  decrease  in
nsertion  time  measurements,  when  delta  was  assumed  to  be
.25  and  SD  as  2.0,  with  90%  power  and  ˛:  0.05,  the  sample
ize  (n)  was  calculated  to  be  minimum  55  for  each  group.
onsidering  a  10%  drop-out  rate,  the  number  of  subjects  was
alculated  to  be  60  in  each  group.
All  statistical  analyses  were  performed  by  using  SPSS
5.0  software  package  (SPSS  Inc.,  Chicago,  IL,  USA).  T  test
or  independent  samples  was  used  to  compare  two  groups
or  data  with  normal  distribution  and  Mann--Whitney  U  test
as  used  for  comparing  data  with  non-normal  distribution.
ates  continuity  correction  test,  Fisher’s  exact  test  and
isher--Freeman--Halton  test  were  used  for  comparison  of
ualitative  data.
All  data  were  summarized  as  mean  ±  SD  for  continuous
ariables,  numbers  and  percentages  for  categorical  varia-
les.  A  p  <  0.05  was  accepted  as  statistically  signiﬁcant.
esults
oth  groups  were  comparable  with  respect  to  age,  male-
o-female  ratio,  height,  weight,  and  body  mass  index.  The
uration  of  operations  was  48  ±  16.1  min  and  47.5  ±  23.5  min
or  i-gel  group  and  the  LMA-C  group,  respectively  (p  =  0.753)
Table  1).
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Table  1  Baseline  characteristics  of  patients  who  underwent  anesthesia  with  the  i-gel  or  Laryngeal  Mask  Airway  Classic  (LMA-C).
Data are  expressed  as  mean  ±  SD.
i-gel  (n  =  59)  LMA-C  (n  =  59)  p
Age  (years)  48  ±  15  50  ±  17  0.619
Weight (kg)  77.9  ±  10.5  75.9  ±  14.1  0.384
Height (cm)  169.1  ±  9.9  168.  4  ±  8.1  0.656
Body mass  index  (kg/m2)  27.3  ±  3.5  26.7  ±  4.4  0.436
Duration of  surgery  (min)  48.6  ±  16.1  47.  5  ±  23.5  0.753
Table  2  Comparative  data  for  the  i-gel  and  Laryngeal  Mask  Airway  Classic  (LMA-C).  Data  are  expressed  as  number  (proportion)
or mean  ±  SD.
i-gel  (n  =  59)  LMA-C  (n  =  59)  p
Insertion  time  (s) 11.6  ±  2.4 13.1  ±  1.8 0.001
Peak airway  pressure  (cm  H2O) 12.4  ±  2.2 12.6  ±  2.4 0.753
Glottic viewa 0.001
4 19  (32.2%)  1  (1.7%)
3 16  (27.1%)  10  (16.9%)
2 14  (23.7%)  19  (32.2%)
1 10  (16.9%)  29  (49.2%)
a The glottic view via ﬁberoptic examination was scored using the 
arytenoid visible; score 2, only epiglottis visible; score 1, larynx not vi
120 patients
LMA-C (n=60)
1st attempt
53/60(89.8%)
2nd attempt
1/60(1.69%)
3rd attempt
5/60(8.4%)
3rd attempt
3/60(5%)
2nd attempt
3/60(5%)
1st attempt
53/60(89.8%)
i-gel (n=60)
Failure 1/60Failure 1/60
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Digure  1  Flow  chart  of  the  study,  showing  the  subdivision  into
roups  corresponding  to  each  supraglottic  airway  device.
In  the  i-gel  group,  the  SGAD  was  successfully  inserted  in
3  patients  (89.8%)  at  the  ﬁrst  attempt,  in  three  patients
5.0%)  at  the  second  attempt,  and  in  three  patients  (5.0%)
t  the  third  attempt.  In  the  LMA-C  group,  the  SGAD  was
uccessfully  inserted  in  53  patients  (89.8%)  at  the  ﬁrst
ttempt,  in  one  patient  (1.69%)  at  the  second  attempt,  and
n  ﬁve  patients  (8.4%)  at  the  third  attempt.  There  were  two
atients  in  whom  neither  the  i-gel  nor  the  LMA-C  could  be
nserted.  There  was  no  statistical  difference  between  two
roups  regarding  to  success  of  insertion  of  SGAD  (p  =  0.951)
Fig.  1).
Duration  of  laryngeal  mask  insertion  time  in  the  i-gel
roup  was  signiﬁcantly  shorter  than  that  in  group  LMA-C.
O
i
bfollowing: score 4, clear view of the vocal cords; score 3, only
sible.
he  mean  laryngeal  mask  insertion  times  were  11.6  ±  2.4  s
n  i-gel  and  13.1  ±  1.8  s  in  LMA-C  group  (p  = 0.001).  Three
atients  in  group  LMA-C  (5.0%)  and  ﬁve  patients  in  group
-gel  (8.4%)  suffered  from  hiccups,  which  was  the  only
omplication  (p  =  0.717).  No  laryngospasm  and  apnea  were
bserved  in  any  of  the  patients.
Peak  airway  pressure  values  measured  by  the  venti-
ator  were  remarkably  close  for  the  two  groups.  The
ean  peak  airway  pressures  were  12.4  ±  2.2  cm  H2O  and
2.6  ±  2.4  cm  H2O  in  i-gel  group  and  LMA-C  group,  respec-
ively  (p  =  0.753).  The  ﬁberoptic  view  scores  for  the  i-gel
roup  were  signiﬁcantly  better  than  that  for  the  LMA-C  group
p  =  0.001)  (Table  2).
There  were  no  signs  of  methylene  blue  dye  in  ﬁberoptic
iew  at  beginning,  after  insertion  of  devices,  and  just  before
emoval  of  devices  in  both  groups.  Bluish  discoloration  was
ot  seen  after  removal  of  any  of  the  devices.
Blood  staining  was  encountered  rarely  after  removal  of
he  devices  in  both  groups;  however,  it  was  comparable
etween  the  groups  (5  in  group  i-gel  [8.5%]  and  3 in  group
MA-C  [5.1%])  (p  =  0.717).  Postoperative  interview  revealed
 notable  incidence  of  sore  throat  in  both  groups.  Ten
atients  of  group  i-gel  (16.9%)  and  ﬁve  patients  of  group
MA-C  (8.5%)  reported  sore  throat  at  the  postanesthesia  care
nit  (p  =  0.169).  Also,  there  was  no  difference  between  the
roups  regarding  sore  throat  at  24  h  questioning  (p  = 0.752)
Table  3).
iscussionur  results  demonstrate  that  i-gel  has  a  similar  performance
n  terms  of  insertion  success,  peak  airway  pressure,  the  num-
er  of  manipulations  required  for  adequate  positioning,  and
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Table  3  Side  effects  observed  in  study  groups.
i-gel  (n  =  59)  LMA-C  (n  =  59)  p
Signs  of  regurgitation 0  0
Blood staining  5  (8.5%)  3  (5.1%)  0.717
Sore throat  in  PACU  10  (16.9%)  5  (8.5%)  0.169
Sore throat  after  24  h  1  (1.7%)  1  (1.7%)  0.752
Hiccups 5  (8.5%)  3  (5.0%)  0.717
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the  number  of  gastric  regurgitation  compared  with  the  LMA-
C.  However,  i-gel  has  advantages  over  the  LMA-C  in  terms  of
shorter  insertion  times  and  improved  ﬁberoptic  views  of  the
glottis.
Our  study  showed  high  success  rates  of  insertion  with
both  devices,  which  is  in  agreement  with  data  existing  in
the  literature.  In  Gatward  et  al.11 study,  they  obtained  a
86%  success  rate  in  i-gel  insertion  at  the  ﬁrst  attempt,  and
the  overall  insertion  success  rate  was  100%,  similar  to  the
LMA-C  and  the  proseal  LMA  (PLMA).  Ali  et  al.12 had  a  success
rate  of  77%  for  LMA-C  insertion  and  a  success  rate  of  88.5%
for  LMA-Supreme  at  the  ﬁrst  attempt  in  their  study.  Richez13
also  showed  a  comparable  success  rate  for  placement  of  the
i-gel.  In  contrast  to  these  studies,  in  Amini  et  al.’s  study14
comparing  i-gel  and  intersurgical  solus  LMA,  they  found  that
i-gel  group  required  more  interventions  on  the  airway  than
the  intersurgical  solus  LMA  group.  They  thought  it  might  be
because  of  lack  of  experience  of  the  anesthesiologists.  In
our  study,  i-gel  has  a  similar  performance  in  terms  of  inser-
tion  success  compared  with  LMA-C,  and  no  intervention  was
required  during  maintenance  of  anesthesia.  SGADs  were  suc-
cessfully  inserted  in  89.8%  of  patients  at  the  ﬁrst  attempt
in  the  LMA-C  and  in  the  i-gel  group.  This  may  be  explained
by  the  presence  of  experienced  instructor  in  placing  both
SGADs.
Our  results  demonstrate  shorter  insertion  times  for  the
i-gel  compared  with  the  times  for  LMA-C,  probably  because
of  the  fact  that  less  ﬂexible  stem  of  the  i-gel  makes  inser-
tion  easier  and  without  any  need  for  cuff  inﬂation.  Insertion
success  and  shorter  insertion  times  inﬂuence  the  feasi-
bility  of  SGADs,  as  determined  by  Uppal  and  Amini  and
colleagues14,15;  we  found  that  the  insertion  time  was  shorter
in  the  i-gel  group  but  we  did  not  ﬁnd  any  signiﬁcant  clinical
difference  in  this  regard.
Many  investigators  have  demonstrated  that  there  are
no  signiﬁcant  differences  in  oropharyngeal  leak  pressure
between  the  i-gel  and  LMA-Supreme.16,17 Chen  et  al.’s18
meta-analyses  revealed  that  there  were  similar  orop-
haryngeal  leak  pressures  during  anesthesia  between  the
LMA-Supreme  and  the  i-gel.  In  some  studies,  the  LMA
Supreme  is  reported  to  have  higher  oropharyngeal  leak  pres-
sure  than  the  LMA-C.12,17 Although  the  i-gel  does  not  have  an
inﬂatable  cuff  and  thus  it  is  harder  to  adjust  the  seal,  given
Chen  et  al.’s  meta-analyses  of  oropharyngeal  leak  pressures
of  i-gel  and  LMA-Supreme  and  various  investigators’  com-
parisons  of  oropharyngeal  leak  pressures  of  LMA  Supreme
and  LMA-C,  it  can  be  deduced  that  i-gel  might  have  same
or  higher  amounts  of  oropharyngeal  leak  pressure  than  LMA-
C.12,16--19 Further  studies  on  the  most  common  alternative
SGADs  suggest  that  a  mean  peak  airway  pressure  of  more
i
r
m
than  20  cm  H2O  increases  the  risk  of  leakage  with  resultant
nsufﬁcient  ventilation  and  increased  risk  of  aspiration.20,21
n  our  study,  the  i-gel  demonstrated  similar  peak  airway
ressures  (mean  12  cm  H2O)  with  7  mL  kg−1 tidal  volume,  to
he  LMA-C  and  was  comparable  with  the  LMA-C  in  other
tudies  and  less  than  20  cm  H2O.22
In  our  study,  we  had  better  glottic  view  in  i-gel  group
y  ﬁberscopy  and  similar  results  were  reported  in  a  cohort
tudy  performed  by  Beringer  et  al.23 as  well  as  a  number
f  adult  studies.17,18 We  think  that  the  reason  for  ﬁberop-
ic  view  of  glottis  not  being  good  enough  in  LMA-C  group
ight  be  due  to  malposition  caused  by  cuff  of  LMA-C.  The
beroptic  view  depends  on  the  hypopharyngeal  position  of
he  SGAD  and  whether  the  epiglottis  is  folded  down  during
nsertion  or  not.  However,  it  was  shown  that  there  is  no  cor-
elation  between  ﬁberoptic  view  and  SGAD’s  function.  The
beroptic  score  conﬁrms  that  the  SGAD  occupies  a  favorable
natomical  location  to  ensure  unimpeded  ventilation,  with
ower  leak  pressures  and  less  gastric  insufﬂation.23
In  many  studies  that  investigate  SGAD  regurgitation,  it
as  been  shown  that  the  presence  of  SGAD  results  in  a
eaction  in  the  pharynx  which  causes  a  reﬂex  relaxation
t  the  lower  esophageal  sphincter  as  well  as  a  decrease  in
ower  esophageal  sphincter  pressure.7,8,24 This  mechanism
ight  be  more  active  during  superﬁcial  anesthesia.  Inade-
uate  anesthesia  level  and  inexperience  with  the  SGAD  use
ay  increase  the  risk  of  regurgitation.  Bapat  et  al.25 con-
luded  that  they  did  not  encounter  any  regurgitation  even
n  patients  with  high  risk  in  their  study  because  of  an  experi-
nced  SGAD  user.  Another  study  with  280  patients  using  i-gel
emonstrated  that  three  patients  suffered  from  regurgita-
ion  and  one  of  them  resulted  in  aspiration.  This  patient’s
upraglottic  device  was  replaced  by  a  medical  student.26
rimacombe22 has  suggested  two  distinct  learning  curves
n  the  use  of  SGAD,  and  we  believe  that  the  high  inci-
ence  of  regurgitation  cited  in  the  earlier  studies  might  have
ccurred  during  the  learning  curve.  We  controlled  depth
f  anesthesia  with  BIS  monitoring,  and  maintained  it  at
etween  50  and  60,  with  an  experienced  anesthesiologist
lacing  both  SGADs’.
The  measurement  of  hypopharyngeal  pH  is  an  another
ethod  to  detect  gastric  regurgitation,  but  hypopharyngeal
H  is  measured  at  a  single  level  and  thus  may  not  accu-
ately  reﬂect  the  actual  incidence  of  silent  regurgitation.27
he  validity  of  the  methylene  blue  method  to  detect  regur-
itation  is  questionable,  because  disintegration  of  a capsule
n  the  esophagus  may  lead  to  a  falsely  high  incidence  of
egurgitation.8 In  our  study,  to  reduce  false  positives,  the
ethylene  blue  capsule  was  ingested  with  30  mL  water  in
he  upright  position.  Also,  we  visualized  oropharynx  of  the
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atients  10  min  after  the  ingestion  of  the  drug  in  case  of
alse  positive  blue  dye.
Several  limitations  exist  in  this  study.  Firstly,  unblinded
bservers  collected  all  the  data.  Secondly,  the  anesthesiol-
gist  inserting  the  SGADs  had  considerably  more  experience
n  inserting  the  LMA-C  and  the  i-gel  and  this  may  have
ntroduced  bias  in  the  results.  Thirdly,  the  devices  were
sed  in  non-obese  patients  and  in  those  without  underly-
ng  gastrointestinal  system  disorders.  The  results  cannot  be
xtrapolated  to  other  groups  of  patients.
In  conclusion,  our  study  demonstrates  that  both  devices
ad  good  performance  with  low  postoperative  complications
nd  without  occurrence  of  regurgitation.  The  i-gel  provided
 shorter  insertion  time  and  a  better  ﬁberoptic  view  than
he  LMA-C.
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